| ²é¿´: 1766 | »Ø¸´: 4 | ||
lixiangrong1Ìú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÎÄÕÂÈôóÐÞ£¬È´¿´²»¶®Éó¸åÈËÌáµÄÒâ¼ûÊÇʲôÒâ˼£¡Çó·Ò룡
|
|
ÎÄÕÂÈôóÐÞ£¬Éó¸åÈ˸øµÄÒâ¼ûÈçÏ£ºµÚÒ»¸öÒâ¼û¿ÉÒÔ¿´¶®£¬ÊÇÈÃÐÞ¸ÄÐ÷ÂۺͲο¼ÎÄÏ×£¬µ«ÊÇWhich are the implication in term of pharmacokinetic and physiopathologic consequences? Which are the implications of the results? How do the results may be interpreted in term of molecular binding ? È´²»Ì«Ã÷°×ÊÇʲôÒâ˼£¡Ï£ÍûÓ¢ÓïºÃµÄǰ±²¸øÓèÖ¸µ¼£¡Ð»Ð»£¡ The manuscript should be consistently rearranged: Introduction requires an exhaustive description of abumin and its binding properties. The references are not complete, more recent references should be inserted. Which are the implication in term of pharmacokinetic and physiopathologic consequences? Which are the implications of the results? How do the results may be interpreted in term of molecular binding ? |
» ²ÂÄãϲ»¶
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ21È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ3È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ16È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ4È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ9È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ18È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ7È˻ظ´
ÅóÓÑȦ¿´µ½µÄ
ÒѾÓÐ9È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÎÄÕ´óÐÞ£¬¿ÉÊÇÉó¸åÈ˵ÄÎÊÌâºÜ¸´ÔÓ£¬½â¾ö²»ÁËÔõô°ì£¿
ÒѾÓÐ25È˻ظ´
ÒÑÊÕµ½Decision lettlerÒªÇó´óÐÞ£¬Ò»ÖÜÓÖÊÕµ½ÐµÄÉó¸åÈËÒâ¼û£¬ÐèÒª»Ø´ðÐÂÉó¸åÈËÒâ¼ûÂð
ÒѾÓÐ9È˻ظ´
SCIÎÄÕ´óÐÞ,ËĸöÉó¸åÈË,ÓÐÒ»¸ö²»Í¬Òâ·¢±í,´óÐÞ·µ»Øºó,¾ÝµÄÕâ¸öÉó¸åÈË̬¶È»á¸Ä±äÂð
ÒѾÓÐ15È˻ظ´
´óÐ޺󱻱༾ܵô£¬ÖØÍ¶»á»»Éó¸åÈËÂð£¿
ÒѾÓÐ13È˻ظ´
Á½¸öÉó¸åÈËÈôóÐÞ£¬Çë½ÌÖ÷±à¾Ý¸åºóÈÃÐ޸ĺóÖØÍ¶µÄÎÊÌâ
ÒѾÓÐ28È˻ظ´
´óÐÞºó£¬Éó¸åÈËÌá³öÁËÒ»¸öͼµÄÎÊÌ⣬Ôõô½âÊͰ¡£¿
ÒѾÓÐ82È˻ظ´
ÎÄÕ´óÐÞ£¬ÊÇ·ñ¿ÉÒÔÏòÖ÷±àѯÎÊÉó¸åÈ˵ĵØÖ·£¿
ÒѾÓÐ38È˻ظ´
ÎÄÕ´óÐÞ£¬ÕâÖÖÇé¿ö£¬Ôõô»Ø¸´Éó¸åÈ˰¡£¿
ÒѾÓÐ26È˻ظ´
³õÉóÒâ¼ûÁ½¸öÉó¸åÈË£¬Ò»¸öÇ¿µ÷´´ÐÂÐÔ²»Ç¿£¬Ò»¸öÒªÇó´óÐÞ. ¸Ã ÔõÑù»Ø¸´°¡£¿ лл
ÒѾÓÐ39È˻ظ´
ÍâÉó»ØÀ´ÁË£¬±à¼¸øÁË´óÐ޵Ļú»á£¬(˵·þ¾ÜÎÒµÄÉó¸åÈË~) ÇóÉñÖú
ÒѾÓÐ4È˻ظ´
´óÐÞÖ®ºó»¹»áËÍÔÀ´µÄÉó¸åÈËÂð£¿
ÒѾÓÐ12È˻ظ´
Éó¸åÈËÒªÇó´óÐÞ£¬È´±»±à¼¸ø¾ÜÁË£¬ÊÇ·ñ¿ÉÒÔÉêËߣ¿
ÒѾÓÐ15È˻ظ´
SCIÒ»Éó´óÐÞ£¬µ«ÊÇÈò¹µÄʵÑéûÓÐÒâÒ壬զ°ìÄØ£¿½âÊ͸øÉó¸åÈËÌý£¿
ÒѾÓÐ11È˻ظ´
´óÐÞÎÄÕÂÄÜÌí¼ÓÉó¸åÈËû˵µÄж«Î÷Âð£¿
ÒѾÓÐ6È˻ظ´
ͶÁËһƪӢÎÄÎÄÕ£¬Éó¸åÈ˿϶¨ÁËÏë·¨£¬µ«Êǽ¨Òé¾Ý¸å¡£¿ÉÖ÷±à¸ø³ö´óÐÞ¡£
ÒѾÓÐ22È˻ظ´
Éó¸åÈË˵´óÐÞ£¬µ«ÊÇÂÛÎı»¾Ü£¬¸ø±à¼ÔÙ·¢ÓʼþÉêËßÓÐÓÃÂð 7.19 ¸üÐÂ
ÒѾÓÐ30È˻ظ´
ÎÄÕ´óÐÞÉó¸åÈËÌá³öµÄÎÊÌâÓÐÒ»¸ö²»ÄܽâÊÍÔÒò»¹Äܱ»Â¼ÓÃÂð
ÒѾÓÐ11È˻ظ´
JAPÎÄÕ´óÐÞºó£¬Éó¸åÈËÉñËٻظ´£¨20·ÖÖÓ£©£¬²»ÖªÊÇÐ×ÊǼª¡¾ÒѾ½ÓÊÜ£¬Ð»Ð»¸÷λ¹ØÐÄ¡¿
ÒѾÓÐ39È˻ظ´
ÈçºÎÔÚ´óÐÞºóµÄÎÄÕÂÀïÌåÏÖÕë¶ÔÉó¸åÈËÒâ¼ûµÄÐ޸ģ¿
ÒѾÓÐ12È˻ظ´
Éó¸åÒâ¼û»ØÀ´£¬Ò»¸öÉó¸åÈËÈþݣ¬±à¼Ëµ´óÐÞ£¬´ó¼Ò°ïÎÒ¿´¿´Ï£Íû´ó²»
ÒѾÓÐ24È˻ظ´
biology-boy
½û³æ (ÕýʽдÊÖ)
¡ï
zxhappy: ½ð±Ò+1, O(¡É_¡É)Oлл³æÓÑÈÈÐÄӦף~~ 2013-06-25 15:52:07
zxhappy: ½ð±Ò+1, O(¡É_¡É)Oлл³æÓÑÈÈÐÄӦף~~ 2013-06-25 15:52:07
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
2Â¥2013-06-25 15:34:34
lixiangrong1
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 10.9
- ºì»¨: 1
- Ìû×Ó: 289
- ÔÚÏß: 81.3Сʱ
- ³æºÅ: 1672931
- ×¢²á: 2012-03-07
- רҵ: ÈÈÁ¦Ñ§
3Â¥2013-06-25 15:41:56
ahauzq
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 64.5
- Ìû×Ó: 2
- ÔÚÏß: 6Сʱ
- ³æºÅ: 763487
- ×¢²á: 2009-05-05
- רҵ: ÐóÄÁѧ
4Â¥2013-06-25 21:33:15
changjiang_ttl
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 9592.9
- Ìû×Ó: 185
- ÔÚÏß: 608.6Сʱ
- ³æºÅ: 148520
- ×¢²á: 2005-12-28
- ÐÔ±ð: GG
- רҵ: ÖÆÒ©¹¤³Ì
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
lixiangrong1: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2013-07-01 17:59:49
lixiangrong1: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2013-07-01 17:59:49
|
ÊÖ¸åÒª´ÓбàÅÅ£º ½éÉܲ¿·Ö¸ø³öabumd Ïêϸ˵Ã÷/ÃèÊöÒÔ¼°ËüµÄ°ó¶¨ÌØÕ÷µÈÄÚÈÝ£¬ÒýÓÃÎÄÏײ»ÍêÉÆ£¬ÐèÒª¶à²åÈëһЩ×îÐÂÄÚÈݵIJο¼ÎÄÏ×ÐÅÏ¢¡£ ÄÄЩÄÚÈÝÊÇÒª¸ù¾ÝÒ©ÎﶯÁ¦Ñ§ºÍ²¡ÀíÉúÀíѧµÄÌØÕ÷/½á¹ûÀ´ËµÃ÷¡£ ÄÄЩµØ·½ÊÇչʾ/˵Ã÷½á¹û¡£ ¸ù¾Ý·Ö×Ó½¡ÄÚÈÝÔõÑùÀ´½âÊÍÄãµÄ½á¹û ´ó¸ÅÊÇÕâÑùµÄ£¬×¨Òµ´Ê»ã·ÒëµÄ²»×¼Çë×ÔÐÐÈ·ÈÏ¡£ |
5Â¥2013-06-27 05:17:38









»Ø¸´´ËÂ¥
20